-
MAY 20-22 | CHITOSE at INTERPHEX WEEK 2026: Showcasing Cell Line Development Platform Reaching 10 g/L in 5 Days
-
The University of Tokyo and Chitose Laboratory Drive New Development in Digital Design for Manufacturing Process of Antibody Drugs ―Mathematical model development of cultivation process with full utilization of data from automated experiments―
-
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
-
Paper on Novel CHO-MK Cell Line Receives 2025 Excellent Paper Award from the Society of Biotechnology, Japan
-
CHITOSE Group, Prodezi Long An Corporation and TA Vital Join Forces to Build a Sustainable Industrial Park in Vietnam
-
CHITOSE Group Announces Capital Raising of JPY 500 Million from NSK ltd. and Conclusion of Business Alliance Agreement
-
MYCENAX and Chitose Laboratory Corp. to Scale-Up Production and Strengthen Marketing Activities for CHO-MK Cells
-
Starting the trial sale of organic fertilizer ‘Trichoderma fortified compost’ developed together with Sime Darby Plantation in Malaysia.
